Vimentin Antibody, anti-human, REAfinity™
Synonyms: VIM, CTRCT30, HEL113
RECOMBINANT
Bioz Star94/100 Bioz rating
24 Citations4 Images
Clone:
REA409 | RV202
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, 3D-IF, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for Vimentin Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
FITC
PE
Vio B515
Vio R667
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-118-497, 130-118-361
Description:
Human mesenchymal stem cells (MSC), harvested and cultured from normal bone marrow, were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-Vimentin antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application image
MICS (MACSima Imaging Cyclic Staining) applications
APC
FITC
PE
Fixation:
frozen – PFA
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC, ICC
Conjugate:
APC
Used products:
130-118-497, 130-118-361
Testing grade:
Fixation:
frozen – Acetone
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-118-497, 130-118-361
Testing grade:
Fixation:
FFPE
Species tested:
human
Tissue used:
tonsil
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-118-497, 130-118-361
Testing grade:
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin-embedded (FFPE) tonsil section. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using Vimentin APC (green) for 10 minutes at room temperature. Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

Application image
3D-Immunofluorescence applications
Vio 780
Vio G570
Vio R667
Tissue clearing:
MACS® Deep Clearing Kit
Fixation:
PFA
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
Vio 780
Used products:
130-136-619
Description:
3D-immunofluorescence analysis of human ovarian cancer fixed with 4% PFA and subjected to whole-mount immunostaining with Vimentin Antibody, anti-human, Vio® 780 (magenta). The sample was processed and optically cleared using the MACS® Deep Clearing Kit and imaged with an UltraMicroscope Blaze light sheet instrument. Sample detail image (A), overview image (B, autofluorescence in grey). The image was processed using Destripe and Contrast Compression in MACS® iQ View – 3D Large Volume Software. Scale bars: 100 µm (A), 1000 µm (B).

Application imageView details view details

Application imageView details view details
Specifications for Vimentin Antibody, anti-human, REAfinity™
Overview

Clone REA409 recognizes the human vimentin antigen, a 57 kDa molecule which is one of the most widely expressed and highly conserved proteins of the type III intermediate filament (IF) protein family. Vimentin is expressed in a wide range of cell types, including pancreatic precursor cells, sertoli cells, neuronal precursor cells, trophoblastic giant cells, fibroblasts, endothelial cells lining blood vessels, renal tubular cells, macrophages, neutrophils, mesangial cells, leukocytes, and renal stromal cells. Increased vimentin expression has been reported in various epithelial cancers including prostate cancer, gastrointestinal tumors, CNS tumors, breast cancer, malignant melanoma, lung cancer, and other types of cancers. Vimentin's over-expression in cancer correlates well with increased tumor growth, invasion, and poor prognosis. Vimentin has gained much importance as a canonical marker of epithelial-mesenchymal transition (EMT), a cellular re-programming process in which the epithelial cells acquire a mesenchymal phenotype that renders the cells to dramatically alter their shape and exhibit increased motility. This EMT is characterized by the expression of vimentin IFs in epithelial cells, which normally express only keratin IFs. Accordingly, during the reverse process of EMT, known as mesenchymal-epithelial transition (MET), the cells start acquiring epithelial phenotype and show a decreased vimentin expression with lower motility rates.

Additional information: Clone REA409 displays negligible binding to Fc receptors.

Alternative names

VIM, CTRCT30, HEL113

Detailed product information

Technical specifications

Clone
REA409
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat, other
Cross-reactivity
rat, mouse, hamster, monkey, dog, chicken, rabbit, cow, goat
Antigen
Vimentin
Molecular mass of antigen [kDa]
54
Distribution of antigen
Sertoli cells, endothelial cells, fibroblasts, macrophages, neutrophils, pancreas
Entrez Gene ID
RRID
AB_2905456, AB_2905457, AB_2727581, AB_2889795, AB_2751530, AB_2889796, AB_2727645, AB_2751494

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Vimentin Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?